For further details see:
Bristol Myers' deucravacitinib maintains efficacy at 2 years against plaque psoriasis in studyFor further details see:
Bristol Myers' deucravacitinib maintains efficacy at 2 years against plaque psoriasis in studyMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
Market:
2024-05-03 09:30:00 ET Some investors view growth or momentum stocks as the key to multi-bagger returns. Others prefer to deep-sea dive for beaten-down assets with rebound potential. The compounding effect of dividend reinvestment over enough time can potentially make it possible to turn $1...
2024-05-03 07:15:00 ET It's a reasonable question: If you'd invested $1,000 in pharmaceutical specialist Bristol Myers Squibb (NYSE: BMY) five years ago in 2019, how much would you have today? You might ask that if you've been thinking of investing in the company or holding its ...
CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced a two-year extension to the collaboration with Bristol Myers Squibb (NYSE: BMY) under which the parties may research, develop, and commercialize autologo...